Get 20% lifetime commission for referring investors to digrin.com
here.
Hepion Pharmaceuticals, Inc. ( HEPA) - Key Metrics
HEPA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.08 | -$0.09 | -$0.09 |
| 2026Q1 | $0 | -$0.07 | $0.05 | $0.05 |
| 2025Q4 | $0 | -$0.07 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.04 | -$0.04 | -$0.04 |
| 2025Q2 | $0 | -$0.09 | -$0.12 | -$0.12 |
HEPA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.22 |
| 2026Q1 | 0% | -0.20 |
| 2025Q4 | 0% | -0.27 |
| 2025Q3 | 0% | -0.31 |
| 2025Q2 | 0% | -0.22 |
HEPA
Price: $0.10
52 week price:
Earnings Per Share: -0.31 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 70741
Market Capitalization: 12.1 million